U-HCWB

Q:HCWB - HCW BIOLOGICS INC - Website unknown - click to update

14:03:50 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
HCWB - Q	0.1	0.9237	·	1.27	0.1	1.10			20.5	19	76	1.10 1.16 1.10	2.32 0.91	19:30:21	May 15	15 min RT 2¢

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market: Nasdaq -- Bid Tick: Down -- UPC Restricted: No

Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · 1yr Bulletins · Historical · Options · Portfolio

Recent Trades - Last 10 of 76

More trades...

Time ET	Ex	Price	Change	Volume
19:30:21	Q	1.01	-0.09	1
16:00:01	Q	1.10		20
16:00:01	Q	1.10		29
16:00:01	Q	1.10		12
16:00:01	Q	1.10		5
16:00:01	Q	1.10		10
16:00:01	Q	1.10		100
16:00:00	Q	1.10		31
16:00:00	Q	1.10		461
15:59:56	Q	1.11	0.01	15

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Type	Headline
2024-05-15 16:39	U:HCWB	News Release200	HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights
2024-04-01 16:11	U:HCWB	News Release200	HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights
2023-11-14 07:01	U:HCWB	News Release200	HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights
2023-11-08 07:30	U:HCWB	News Release200	Investigator Sponsor of HCW Biologics ¢ € ™ Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting
2023-11-01 07:31	U:HCWB	News Release200	Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting
2023-09-06 07:30	U:HCWB	News Release200	HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 ¢ € “ 13, 2023
2023-08-11 07:00	U:HCWB	News Release200	HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
2023-06-14 07:30	U:HCWB	News Release200	HCW Biologics is Granted Third Fundamental Patent: ‚ U.S. Patent for Methods of Treating Age-Related Disorders

Date ET

Symbol

Type

Headline

2024-05-15 16:39

U:HCWB

News Release

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

2024-04-01 16:11

U:HCWB

News Release

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights